Basics Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $4B Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 2.77% Avg Daily Range (30 D): $0.63 | 2.83% Avg Daily Range (90 D): $0.48 | 2.63% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): 1.31M Avg Daily Volume (90 D): 1.3M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 2,896 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $3.63M Avg Inst. Trade (90 D): $2.91M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.55M Avg Closing Trade (30 D): $5.56M Avg Closing Trade (90 D): $4.32M Avg Closing Volume: 160.21K     News Sep 17, 2025 @ 9:49 PM CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER... Source: Kahn Swick & Foti, Llc Sep 3, 2025 @ 10:17 PM Why Immunovant Stock Blasted Higher Today Source: Eric Volkman Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc. Aug 11, 2025 @ 11:27 AM Immunovant Posts 34% R&D Jump in Q1 Source: Jesterai Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Financials   TTM Q2 2026 Q1 2026 Basic EPS $-2.83 $-.73 $-.71 Diluted EPS $-2.83 $-.73 $-.71 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -464.69M $ -126.5M $ -120.61M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 240.72M $ -.88M $ .57M PE Ratio